ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag viral latency genetics genomics evolution

Different colored cartoon viruses entering holes in a cartoon of a human brain.
A Journey Into the Brain
Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Illustration showing a puzzle piece of DNA being removed
Large Scientific Collaborations Aim to Complete Human Genome
Brianna Chrisman and Jordan Eizenga | Sep 1, 2022 | 10+ min read
Thirty years out from the start of the Human Genome Project, researchers have finally finished sequencing the full 3 billion bases of a person’s genetic code. But even a complete reference genome has its shortcomings.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Recoding Life
Laasya Samhita | Jan 2, 2014 | 6 min read
Rewriting the genetic code can lead to a better understanding of how living cells work, and spawn new biotechnological applications.
3D virus cells attacking a DNA strand
HIV DNA Circularizes to Bypass CRISPR-Based Treatments
Nele Haelterman, PhD | Mar 7, 2022 | 3 min read
CRISPR-mediated removal of HIV can create small, infectious DNA molecules.
Research Notes
Eugene Russo | Jun 25, 2000 | 5 min read
Putting Polio to Good Use Add polio to a host of other viral and bacterial foes that, in modified forms, could prove therapeutically beneficial. Although Russian scientists attempted to use polio to treat cancer in the 1960s--unpublished experiments about which little is known--a recent brain cancer study in mice is the first modern-day attempt to harness the power of the virus (M. Gromeier et al., "Intergeneric poliovirus recombinants for the treatment of malignant glioma," Proceedings of the
Blotting Technology's Permanence Is Assured As Its Applications In The Laboratory Flourish
Holly Ahern | Nov 27, 1994 | 10 min read
Advanced Biotechnologies Inc. Columbia, MD Advanced Genetic Technologies Corp San Diego, CA Ahlstrom Filtration Inc. Mount Holly Springs, PA American Bioanalytical Inc. Natick, MA Boehringer Mannheim Corp. Indianapolis, IN P.J. Cobert Associates St. Louis, MO Crescent Chemical Inc. Hauppauge, NY DuPont NEN Boston, MA Fluka Chemical Corp. Ronkonkoma, NY Gallard-Schlesinger Industries Inc. Carle Place, NY Hoefer Scientific
Blotting Technology's Permanence Is Assured As Its Applications In The Laboratory Flourish
Holly Ahern | Nov 27, 1994 | 10 min read
Advanced Biotechnologies Inc. Columbia, MD Advanced Genetic Technologies Corp San Diego, CA Ahlstrom Filtration Inc. Mount Holly Springs, PA American Bioanalytical Inc. Natick, MA Boehringer Mannheim Corp. Indianapolis, IN P.J. Cobert Associates St. Louis, MO Crescent Chemical Inc. Hauppauge, NY DuPont NEN Boston, MA Fluka Chemical Corp. Ronkonkoma, NY Gallard-Schlesinger Industries Inc. Carle Place, NY Hoefer Scientific
Notebook
Steve Bunk | Nov 7, 1999 | 7 min read
Content Jumping DNA Semen pharming Screening for heart risk Real-time signaling PubSCIENCE starts, PubMedCentral grows When time stands still Shutting down the pump Brain gain JUMPING DNA Mutations aren't transmitted only by inheritance--they can cross species, too, according to recent findings by John F. McDonald, head of the genetics department at the University of Georgia (I.K. Jordan et al., "Evidence for the recent horizontal transfer of long terminal repeat retrotransposon," Proceedings of
A Long Shot on Cytomegalovirus
Alan Dove | Dec 1, 2006 | 10 min read
A Long Shot on Cytomegalovirus An unlikely vaccinologist fights an unlikely foe. By Alan Dove ARTICLE EXTRAS Developing a hybrid CMV vaccine An economic boost for an unlikely target Two sides or more: from scientist to sculptorSlideshow: the artwork of Gerd MaulPodcast: A vaccine for cytomegalovirusProgress toward combating a rare but costly diseaseGerd Maul was frustrated. It was 1989, and the German-born researcher at Philadelphia's Wistar

Run a Search

ADVERTISEMENT